Topadur Pharma AG

Topadur Pharma AG is a Swiss biopharmaceutical start-up that is currently in the clinical-stage. The company is based in Schlieren, Zurich and was established in 2015 by pharmaceutical R&D experts with decades of experience. Topadur specializes in developing innovative treatments for aging-related diseases such as chronic wounds, diabetic retinopathy and pulmonary fibrosis, using its unique DualTOP™ technology platform. Topadur has a highly experienced management and board team with longstanding expertise in research and development, management, and commercialization of pharmaceutical products.